Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Evommune Inc. (EVMN) had Profit Margin of -954.40% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$7.00M |
|
$-66.81M |
|
-- |
|
$7.00M |
|
-- |
|
$7.00M |
|
-- |
|
$7.00M |
|
$7.00M |
|
$7.00M |
|
$-66.81M |
|
$-66.81M |
|
$7.00M |
|
$7.00M |
|
$7.00M |
|
1.51M |
|
1.51M |
|
$-45.29 |
|
$-45.29 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
|
Profit Margin |
-954.40% |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|